AllDocs -> cancers

Guidance for Industry FDA Approval of New Cancer Treatment Uses for Marketed Drug and Biological Products U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) December 1998 Clin 7 Page 2 Guidance for Industry FDA Approval of New Cancer Treatment Uses for Marketed Drug and Biological Products Additional copies are available from: the Drug Information Branch (HFD-210), Center for Drug Evaluation and Research (CDER), 5600 Fishers Lane, Rockville, MD 20857 (Tel) 301-827-4573 Internet at http://www.fda.gov/cder/guidance/index.htm or Office of Communication, Training, and Manufacturers Assistance (HFM-40) Center for Biologics Evaluation and Research (CBER) ...

National Cancer Institute SEER Program 128 CANCER CONTROL IN MINORITY AND UNDERSERVED POPULATIONS C ancer affects various population subgroups in the United States in distinct ways. The statistics in this monograph show that black men have the highest incidence rate of cancer , due to excesses of prostate and lung and bronchus cancers , while American Indian men in New Mexico have the lowest rate. Among women, non-Hispanic white women have the highest incidence rate, due mainly to their excess of breast cancer , while American Indian women in New Mexico and Korean women have the lowest rates. Interestingly, the five most commonly diagnosed cancers among men in every racial/ethnic group include lung and bronchus, prostate and colorectal cancers . Oral cancers , however, are among the five ...

SUMMARY CHILDHOOD CANCER INCIDENCE HEALTH CONSULTATION: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, 1979-1995 FOR DOVER TOWNSHIP (OCEAN COUNTY), NEW JERSEY September 1997 Division of Environmental and Occupational Health Services Consumer and Environmental Health Services In consultation with the Agency for Toxic Substances and Disease Registry Christine Todd Whitman Len Fishman Governor Commissioner Page 2 1 SUMMARY of the technical report on CHILDHOOD CANCER INCIDENCE HEALTH CONSULTATION: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, 1979-1995, FOR DOVER TOWNSHIP, OCEAN COUNTY, NEW JERSEY In the spring of 1995, the New Jersey Department of Health (now the New Jersey Department of Health and Senior Services or NJDHSS) was requested to evaluate childhood ...

Cancer Student Worksheet The following answers are based on pages 44–55: Section one: What is cancer (pages 44–46)? 1. What part of a cell must be damaged before it becomes a cancer cell? The genetic information,DNA. 2. In what ways does a cancer cell behave differently from a normal cell? Cancer cells do not respond to the signals that control normal cell behaviour.They multiply uncontrollably,making many more cancer cells in the process. 3. What results from this behaviour and what can be done about it? The cancer cells usually grow into a lump called a tumour, which can grow to be several cen- timetres wide before it is detected. The tumour can be removed by a surgeon and, if the cancer has not spread to any other parts of the body,the patient can be cured. 4. Why are cancer cells more likely to be found in older people than in children? ...

EPA 402-R-93-076 ESTIMATING RADIOGENIC CANCER RISKS June 1994 U.S. Environmental Protection Agency 401 M Street S.W. Washington, DC 20460 Page 2 ii The scientific basis for this report has been reviewed formally by the Radiation Advisory Committee (RAC) of the EPA Science Advisory Board (SAB). The following paragraph is a synopsis of that review. On January 10, 1992, Margo T. Oge, Director, Office of Radiation Programs (now the Office of Radiation and Indoor Air or ORIA) requested that the RAC review an issues paper comparing health risk estimates due to low level exposures of low-LET radiation based on models recently published by the Radiation Effects Research Foundation, the United Nations, the National Radiological Protection Board of the UK, the National Academy of Sciences, the US Nuclear Regulatory Commission, and the International ...

1 Copyright Reserved W HY DO I NEED A PROSTATE OR CERVI X DETOX PROSTATE PROBLEMS Prostate problems will become a reality for all men during their lifetimes; problems usually begin between the ages of 40-50 and accelerate from that time onward. Prostate cancer is the number two cause of male cancer deaths after lung cancer . Unlike lung cancer , where smoking is the main cause, prostate cancer can effect the most unlikely of people (Lance Armstrong for example). Just in the United States over 300,000 men are diagnosed with prostate cancer each year. At age 50, 40% of men will contract prostate cancer , at age 60 there is a 50% chance and the percentages get worse as we age. (Prevention is better than cure, detox). Alm ost all m en above the age of 40 develop chronic prostatitis (i.e. inflammation or infection of the prostate), which may or may not have overt symptoms (i.e. ...

Cancer Facts & Figures for Hispanics 2000-2001 Page 2 Table of Contents Cancer Statistics for Hispanics 1 Selected Cancers 3 Behavioral Risk Factor Statistics 4 Tobacco Use 4 Overweight, Obesity, and Physical Activity 5 Use of Screening Tests 7 Sources of Statistics 8 References . 8 Acknowledgments The production of this report would not have been possible without the efforts of: Cheryll Cardinez, MSPH, Vilma Cokkinides, PhD, Robert Greenlee, PhD, MPH, April Harris, Mary Beth Hill-Harmon, MSPH, Taylor Murray, Susan Summers, Michael Thun, MD, MS, and Phyllis Wingo, PhD, MS. Cancer Facts and Figures for Hispanics is a periodic publication of the American Cancer Society, Atlanta, Georgia. For more information contact: Kate O’Brien, MPH Vilma Cokkinides, PhD Michael Thun, ...

For more information call toll free: 1-800-ACS-2345 or on the Internet, http://www. cancer .org National Home Office: American Cancer Society, Inc., 1599 Clifton Road NE, Atlanta, GA 30329-4251, (404) 320-3333 National Media Office: 1180 Avenue of the Americas, New York, NY 10036, (212) 382-2169 ©1997, American Cancer Society, Inc. 97-300M-No. 5008.97 The American Cancer Society is the nationwide, community-based, voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer , saving lives and diminishing suffering from cancer , through research, education, advocacy, and service. Page 2 S pecial S ection: RA CIAL AND ETHNI C P A T TER N S Estimated number of new cancer cases in 1997 by state, total: 1,382,400 ...

C ancer U pdate C ancer U pdate Newsletter of the Parliamentary Cancer Information Network Professor Richard Kefford * Leading cancer researchers have predicted that in 20 years time, 80% of cancer patients will not die of their disease, and that the disease will be beaten by 2050. Whilst the precision of such predictions remains arguable, they represent the wave of optimism and excitement within the cancer research community about the impact of modern genomics research on the prospects of rational, targeted, “designer drug” therapy of this disease. O nce cancer has spread to distant organs like the liver, bones and brain, most current treatments have minimal impact on survival. Temporary remissions are possible with chemotherapy, but relapses are usual, ...

Colorectal Cancer Screening With about 135,000 new cases diagnosed each year, colorectal cancer is the fourth most common cancer in the U.S., just behind malignancies of the lung, breast, and prostate. The nations second-leading cause of cancer deaths, it kills more than 55,000 Americans each year. Yet--when caught early--colorectal cancer is among the most treatable of all types of cancer . Unlike many other cancers that can appear suddenly and grow quickly, colon cancer has a long precancerous phase as growths or polyps, which often exist for several years before becoming cancerous. If these growths are discovered and removed promptly, colon cancer can be prevented. Even after colorectal cancer has developed, it's 90 percent curable when found early. Many people who are otherwise conscientious about their health seem to practice a "see-no-evil, "hear-no-evil" approach ...

Frequently Asked Questions about Cancer of the Uterus What is cancer of the uterus? Cancer is a disease in which certain body cells don’t function right, divide very fast, and produce too much tissue that forms a tumor . Cancer of the uterus is cancer in the womb, the hollow, pear-shaped organ where a baby grows during a woman’s pregnancy. There are different types of uterine cancers . Two types are endometrial cancer and uterine sarcomas . In the United States, endometrial cancer is a common cancer of the female reproductive system. This type of cancer happens when cancer begins in the tissue lining the uterus (endometrium). Uterine sarcomas occur when cancer grows in the muscles or other supporting tissues in the uterus. Uterine sarcomas account for only a small portion of cancers of the uterus. Why should I be concerned about cancer of ...

Cancer Institute NSW 50 new cancer care nursing positions in 2004-2006 These frontline nurses will be the pivotal point of contact for patients. They will be given further education to become highly specialised oncology nurses. They will coordinate patient care between different treatments and hospitals. This program will support cancer patients and direct them to key services in metropolitan and rural NSW by guiding patients through the complex medical system and providing the support and education patients need throughout their treatment and recovery. Comprehensive cancer research program A range of research programs will: • Establish a clinical trials program to increase participation in clinical trials of new treatments from 2% towards 10%. • Support and recruit high quality cancer researchers to NSW • Make research discoveries more ...

Changes at the Cochrane Cancer Network The Medical Research Council (UK) has funded the Cochrane Cancer Network since its inception in 1996. In February 2003 a consortium of funders was established to continue the financial support of the network. The consortium consists of the Department of Health, Cancer Research UK and Macmillan Cancer Relief, each contributing a third of the annual funding for 3 core members of Network staff. The previous MRC funding for Dr Chris Williams was on the understanding that his commitment would be full time in the early years of the Network. This enabled the development of the cancer Collaborative Review Groups (CRGs), facilitating the preparation of systematic reviews in cancer and the promotion of Cochrane throughout the global cancer community. It was always anticipated that his involvement would lessen ...

CANCER INSTITUTE NSW RESEARCH PROGRAMS Overview of Cancer Institute NSW research programs guiding principles, priorities and criteria INTRODUCTION Cancer research will provide the evidence that will drive rapid improvement in cancer prevention, treatment and the subsequent improvements in survival and quality of life of cancer patients. The cancer research supported in NSW must be performance driven and deliver meaningful and highly significant outcomes. GUIDING PRINCIPLES The Cancer Institute NSW Research Program is not a duplication of the grants available from the NHMRC or ARC for cancer in NSW. Rather it is strategically designed to specifically address issues of capacity, relevance and competitiveness raised by the Wood’s Report and the Cancer Institute’s own review of cancer research in NSW. The Cancer Institute’s ...

cancer HELPING CHILDREN WHEN A PARENT HAS CANCER INFORMATION AND SUPPORT RESOURCES This Resource List is provided solely as a reference tool and in no way constitutes an endorsement or recommendation by Emory Healthcare or Emory University of the websites or programs listed. Further, neither Emory Healthcare nor Emory University has reviewed the accuracy or the content of these websites or programs. Therefore, you are encouraged to contact these organizations directly to verify and/or obtain additional information regarding the various benefits and programs. Books, Pamphlets, Videos, Websites American Cancer Society. ?Helping Children Understand: A Guide for a Parent with Cancer ? and ?It Helps to Have Friends.? Free pamphlets 1-800-ACS-2345. Balter, Lawrence. Not in Front of the Children: How to Talk to Your Child About Tough Family Matters. ...

Introduction Results Landscaping activity of the tumor suppressor Smad4 as revealed by a “secretome” analysis M. Volmer , Y. Radacz , K. Stühler , S. Klein-Scory , H. E. Meyer , W. Schmiegel , I. Schwarte-Waldhoff 1,2 1 2 1 2 1 1 Laboratory for Immunology and Molecular Biology , Knappschaftskrankenhaus, Ruhr-Universität Bochum Ruhr-Universität Bochum Martin.Volmer@ruhr-uni-bochum.de 1 2 Medical Proteom-Center, 1 2 3 4 5 6 8 7 9 10 1 2 3 4 5 6 8 7 9 10 Matrices were produced by confluent cultures for five days and isolated by removing the cells with a scraper. Indicator cells were allowed to adhere to the matrices for 10-20 minutes. After removal of the non-attached cells, the remaining cells were allowed to spread ...

S PECIAL TO THE I NDEX FORT WORTH – Part human, part mouse – new genetically engineered drugs for advanced colorectal cancer show great promise. The U.S. Food and Drug Administration recently approved two “targetable drugs” – Erbitux and Avastin. These medicines attack specif- ic areas on the cancer cell sur- face as opposed to poisoning the DNA of cancer cells through traditional chemother- apy. “The glass ceiling has been broken with these two drugs. These are tremendous advancements in the treatment of cancer and also carry the benefit of fewer side effects for our patients. The drugs are not only appropriate for patients in the late stages of colon cancer , but also for those who cannot tolerate tra- ditional chemotherapy treat- ment,” said Dr. Ray Page, medical oncologist with ...

cancers cancer Cancer : A cancer is an uncontrolled proliferation of cells. In some the rate is fast; in others, slow; but in all cancers the cells never stop dividing. This distinguishes cancers - malign tumours - from benign growths like moles where their cells eventually stop dividing. Cancers are clones. No matter how many trillions of cells are present in the cancer , they are all descended from a single ancestral cell. Cancers begin as a primary tumour. At some point, however, cells break away from the primary tumour and - travelling in blood and lymph - establish metastases in other locations of the body. Metastasis is what usually kills the patient. Cancer cells contain mutated genes known as oncogenes. The mutations are found in genes that are involved in mitosis; that is, in genes that control the cell cycle. What probably happen is: ...

Curry spices found to fight cancer other diseases Clinical trials under way in California with curcumin for dementia and Alzheimer s BEN MACLENNAN Sapa A GOOD curry laden with spices can do wonders in keeping a range ofdiseases including can cer at bay according to interna tionally acclaimed researcher Professor Bharat Aggarwal No question about it I can commend it again and again he said in Cape Town It is not only cancer there are a number of other diseases right now there are clinical tri als going on in the University of California with curcumin for dementia and Alzheimer s Aggarwal was the main speaker on Wednesday at the opening of a three day conference on the interface between natural products and molecular therapy at the Uni versity of Cape Town s medical school ...

Produced by The Florida Research Consortium and The Tampa Bay Technology Forum Page 1 of 6 Matrix Metalloproteinases as Therapeutic Targets of Cancer and Cardiovascular Diseases Qing-Xiang Amy Sang, Yonghao Jin, Douglas R. Hurst, Hyun I. Park, Yunge Zhao, Tiebang Kang, Aizhen Xiao, Cyrus A. Monroe, Seakwoo Lee, Robert G. Newcomer, Yewseok Suh, and Martin A. Schwartz Qing-Xiang Amy Sang, Ph.D. Associate Professor Department of Chemistry and Biochemistry 262 DLC, Chemistry Research Building, Room 262 Florida State University Tallahassee, Florida 32306-4390 U.S.A. Phone: (850) 644-8683 (office); -4113 (lab) Fax: (850) 644-8281 E-mail: qxsang@chem.fsu.edu http://www.chem.fsu.edu/editors/sang/sang.htm Research/Technology Overview: Overview: (Start typing here, or paste appropriate portion of abstract.) A research/technology ...